Thursday, March 30, 2017

FDA approves first drug for aggressive MS

Ocrevus could become a leading treatment for multiple sclerosis but concerns about side effects linger, say experts

From: http://www.cbsnews.com/news/multiple-sclerosis-drug-ocrevus-ocrelizumab-fda-approved/

No comments:

Post a Comment